chr3-47121171-A-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_014159.7(SETD2):​c.3465T>C​(p.Asn1155Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.613 in 1,613,356 control chromosomes in the GnomAD database, including 305,165 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.65 ( 32842 hom., cov: 32)
Exomes 𝑓: 0.61 ( 272323 hom. )

Consequence

SETD2
NM_014159.7 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.0840

Publications

37 publications found
Variant links:
Genes affected
SETD2 (HGNC:18420): (SET domain containing 2, histone lysine methyltransferase) Huntington's disease (HD), a neurodegenerative disorder characterized by loss of striatal neurons, is caused by an expansion of a polyglutamine tract in the HD protein huntingtin. This gene encodes a protein belonging to a class of huntingtin interacting proteins characterized by WW motifs. This protein is a histone methyltransferase that is specific for lysine-36 of histone H3, and methylation of this residue is associated with active chromatin. This protein also contains a novel transcriptional activation domain and has been found associated with hyperphosphorylated RNA polymerase II. [provided by RefSeq, Aug 2008]
SETD2 Gene-Disease associations (from GenCC):
  • Luscan-Lumish syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • SETD2-related neurodevelopmental disorder without or with macrocephaly/overgrowth
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • Rabin-Pappas syndrome
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • SETD2-related microcephaly-severe intellectual disability-multiple congenital anomalies syndrome
    Inheritance: AD Classification: STRONG Submitted by: ClinGen
  • Sotos syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • intellectual developmental disorder, autosomal dominant 70
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 3-47121171-A-G is Benign according to our data. Variant chr3-47121171-A-G is described in ClinVar as [Benign]. Clinvar id is 586533.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.084 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.75 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SETD2NM_014159.7 linkc.3465T>C p.Asn1155Asn synonymous_variant Exon 3 of 21 ENST00000409792.4 NP_054878.5 Q9BYW2-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SETD2ENST00000409792.4 linkc.3465T>C p.Asn1155Asn synonymous_variant Exon 3 of 21 5 NM_014159.7 ENSP00000386759.3 Q9BYW2-1

Frequencies

GnomAD3 genomes
AF:
0.653
AC:
99148
AN:
151886
Hom.:
32781
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.757
Gnomad AMI
AF:
0.421
Gnomad AMR
AF:
0.665
Gnomad ASJ
AF:
0.593
Gnomad EAS
AF:
0.684
Gnomad SAS
AF:
0.604
Gnomad FIN
AF:
0.630
Gnomad MID
AF:
0.529
Gnomad NFE
AF:
0.599
Gnomad OTH
AF:
0.628
GnomAD2 exomes
AF:
0.638
AC:
159998
AN:
250966
AF XY:
0.626
show subpopulations
Gnomad AFR exome
AF:
0.766
Gnomad AMR exome
AF:
0.755
Gnomad ASJ exome
AF:
0.594
Gnomad EAS exome
AF:
0.679
Gnomad FIN exome
AF:
0.633
Gnomad NFE exome
AF:
0.594
Gnomad OTH exome
AF:
0.622
GnomAD4 exome
AF:
0.608
AC:
888970
AN:
1461350
Hom.:
272323
Cov.:
44
AF XY:
0.606
AC XY:
440308
AN XY:
726996
show subpopulations
African (AFR)
AF:
0.759
AC:
25407
AN:
33464
American (AMR)
AF:
0.742
AC:
33156
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.590
AC:
15413
AN:
26128
East Asian (EAS)
AF:
0.706
AC:
28044
AN:
39696
South Asian (SAS)
AF:
0.595
AC:
51357
AN:
86246
European-Finnish (FIN)
AF:
0.625
AC:
33403
AN:
53412
Middle Eastern (MID)
AF:
0.531
AC:
3064
AN:
5768
European-Non Finnish (NFE)
AF:
0.596
AC:
662280
AN:
1111542
Other (OTH)
AF:
0.610
AC:
36846
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
19625
39250
58874
78499
98124
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18170
36340
54510
72680
90850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.653
AC:
99271
AN:
152006
Hom.:
32842
Cov.:
32
AF XY:
0.651
AC XY:
48363
AN XY:
74308
show subpopulations
African (AFR)
AF:
0.757
AC:
31392
AN:
41448
American (AMR)
AF:
0.665
AC:
10161
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.593
AC:
2055
AN:
3466
East Asian (EAS)
AF:
0.685
AC:
3548
AN:
5178
South Asian (SAS)
AF:
0.604
AC:
2909
AN:
4816
European-Finnish (FIN)
AF:
0.630
AC:
6650
AN:
10560
Middle Eastern (MID)
AF:
0.521
AC:
152
AN:
292
European-Non Finnish (NFE)
AF:
0.599
AC:
40692
AN:
67950
Other (OTH)
AF:
0.629
AC:
1330
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1734
3467
5201
6934
8668
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
778
1556
2334
3112
3890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.617
Hom.:
97740
Bravo
AF:
0.663
Asia WGS
AF:
0.686
AC:
2385
AN:
3478
EpiCase
AF:
0.578
EpiControl
AF:
0.581

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jul 05, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 20, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Luscan-Lumish syndrome Benign:2
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
3.3
DANN
Benign
0.56
PhyloP100
0.084
PromoterAI
-0.031
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6767907; hg19: chr3-47162661; COSMIC: COSV57430115; COSMIC: COSV57430115; API